CORBETTA, BEATRICE
CORBETTA, BEATRICE
Horizontal tunnelling nanotube transfer to rescue dysfunctional mitochondria in diabetic nephropathy
2022-02-17
MicroRNA 146a is associated with diabetic complications in type 1 diabetic patients from the EURODIAB PCS
2021-01-01 Barutta F.; Corbetta B.; Bellini S.; Guarrera S.; Matullo G.; Scandella M.; Schalkwijk C.; Stehouwer C.D.; Chaturvedi N.; Soedamah-Muthu S.S.; Durazzo M.; Gruden G.
Protective effect of the tunneling nanotube-TNFAIP2/M-sec system on podocyte autophagy in diabetic nephropathy
2022-01-01 Barutta, F; Bellini, S; Kimura, S; Hase, K; Corbetta, B; Corbelli, A; Fiordaliso, F; Bruno, S; Biancone, L; Barreca, A; Papotti, M G; Hirsh, E; Martini, M; Gambino, R; Durazzo, M; Ohno, H; Gruden, G
Protective Role of the M-Sec-Tunneling Nanotube System in Podocytes
2021-01-01 Barutta, Federica; Kimura, Shunsuke; Hase, Koji; Bellini, Stefania; Corbetta, Beatrice; Corbelli, Alessandro; Fiordaliso, Fabio; Barreca, Antonella; Papotti, Mauro Giulio; Ghiggeri, Gian Marco; Salvidio, Gennaro; Roccatello, Dario; Audrito, Valentina; Deaglio, Silvia; Gambino, Roberto; Bruno, Stefania; Camussi, Giovanni; Martini, Miriam; Hirsch, Emilio; Durazzo, Marilena; Ohno, Hiroshi; Gruden, Gabriella
Reversal of albuminuria by combined AM6545 and perindopril therapy in experimental diabetic nephropathy
2018-01-01 Barutta F.; Bellini S.; Mastrocola R.; Gambino R.; Piscitelli F.; di Marzo V.; Corbetta B.; Vemuri V.K.; Makriyannis A.; Annaratone L.; Bruno G.; Gruden G.
The future of diabetic kidney disease management: what to expect from the experimental studies?
2020-01-01 Barutta F.; Bellini S.; Corbetta B.; Durazzo M.; Gruden G.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Horizontal tunnelling nanotube transfer to rescue dysfunctional mitochondria in diabetic nephropathy | 2022 | - | |
| MicroRNA 146a is associated with diabetic complications in type 1 diabetic patients from the EURODIAB PCS | 2021 | Barutta F.; Corbetta B.; Bellini S.; Guarrera S.; Matullo G.; Scandella M.; Schalkwijk C.; Stehouwer C.D.; Chaturvedi N.; Soedamah-Muthu S.S.; Durazzo M.; Gruden G. | |
| Protective effect of the tunneling nanotube-TNFAIP2/M-sec system on podocyte autophagy in diabetic nephropathy | 2022 | Barutta, F; Bellini, S; Kimura, S; Hase, K; Corbetta, B; Corbelli, A; Fiordaliso, F; Bruno, S; Biancone, L; Barreca, A; Papotti, M G; Hirsh, E; Martini, M; Gambino, R; Durazzo, M; Ohno, H; Gruden, G | |
| Protective Role of the M-Sec-Tunneling Nanotube System in Podocytes | 2021 | Barutta, Federica; Kimura, Shunsuke; Hase, Koji; Bellini, Stefania; Corbetta, Beatrice; Corbelli, Alessandro; Fiordaliso, Fabio; Barreca, Antonella; Papotti, Mauro Giulio; Ghiggeri, Gian Marco; Salvidio, Gennaro; Roccatello, Dario; Audrito, Valentina; Deaglio, Silvia; Gambino, Roberto; Bruno, Stefania; Camussi, Giovanni; Martini, Miriam; Hirsch, Emilio; Durazzo, Marilena; Ohno, Hiroshi; Gruden, Gabriella | |
| Reversal of albuminuria by combined AM6545 and perindopril therapy in experimental diabetic nephropathy | 2018 | Barutta F.; Bellini S.; Mastrocola R.; Gambino R.; Piscitelli F.; di Marzo V.; Corbetta B.; Vemuri V.K.; Makriyannis A.; Annaratone L.; Bruno G.; Gruden G. | |
| The future of diabetic kidney disease management: what to expect from the experimental studies? | 2020 | Barutta F.; Bellini S.; Corbetta B.; Durazzo M.; Gruden G. |